Table 3.
Correlation between Markers of Bone Health and Markers of Inflammation and Immune Activation
Hip BMD | Spine BMD | Bone Resorption CTX | Bone Formation | |||
---|---|---|---|---|---|---|
Osteocalcin | PINP | 25-OH vitamin D | ||||
Bone Turnover
| ||||||
CTX | −0.16 | −0.16 | -- | -- | -- | -- |
Osteocalcin | −0.18a | −0.13 | 0.56c | -- | -- | -- |
PINP | −0.002 | −0.05 | 0.60c | 0.59c | -- | -- |
25(OH) vitamin D | −0.27c | −0.17a | −0.15 | 0.05 | −0.26b | -- |
| ||||||
Inflammatory Markers
| ||||||
IL-6 | 0.13 | 0.08 | −0.06 | −0.04 | −0.15 | −0.11 |
CRP | 0.11 | 0.09 | −0.11 | −0.08 | −0.06 | 0.02 |
d-dimer | 0.05 | 0.13 | 0.01 | −0.04 | 0.072 | −0.10 |
RANKL | 0.01 | 0.14 | 0.10 | 0.11 | 0.14 | −0.10 |
OPG | 0.02 | 0.10 | −0.10 | −0.07 | −0.09 | 0.15 |
RANKL:OPG | 0.003 | −0.13 | −0.11 | |||
sTNFR-I | −0.07 | −0.04 | −0.03 | 0.09 | −0.07 | 0.17 |
sTNFR-II | −0.04 | −0.08 | 0.10 | 0.07 | 0.001 | 0.10 |
sICAM-1 | −0.03 | −0.04 | −0.20a | −0.03 | −0.03 | 0.16 |
sVCAM-1 | −0.22b | −0.23b | 0.23b | 0.33c | 0.20a | 0.18a |
| ||||||
Cellular T-cell Activation Markers
| ||||||
CD4+ CD38/HLA-DR | 0.005 | −0.01 | 0.009 | 0.05 | 0.12 | −0.04 |
CD4+CD38+HLA-DR+ PD1+ | 0.03 | −0.10 | 0.05 | 0.02 | 0.10 | −0.09 |
CD8+CD38+HLA-DR+ | −0.02 | −0.04 | 0.03 | 0.04 | 0.08 | 0.002 |
CD8+CD38+HLA-DR+ PD1+ | −0.04 | −0.12 | 0.01 | 0.02 | 0.02 | −0.005 |
| ||||||
Soluble Monocyte Activation Markers
| ||||||
sCD14 | −0.10 | −0.05 | −0.002 | −0.020 | −0.02 | 0.13 |
sCD163 | 0.04 | 0.05 | −0.16 | −0.04 | −0.14 | 0.24b |
| ||||||
Cellular Monocyte Activation Markers
| ||||||
CD14dim CD16+ | 0.10 | 0.05 | −0.11 | −0.08 | −0.02 | −0.03 |
CD14+ CD16/TF | 0.06 | 0.08 | −0.03 | −0.04 | 0.09 | 0.18a |
CD14dim CD16/TF | −0.02 | 0.05 | −0.05 | −0.03 | 0.05 | 0.13 |
All values represent Spearman correlation coefficients;
p <0.05;
p <0.01;
p <0.001.
BMD, bone mineral density; CTX, c-terminal collagen crosslinks; PINP, intact N-terminal propeptide of type 1 procollagen; IL-6, interleukin-6; hsCRP, highly sensitive C-reactive protein; RANKL, receptor activator of NF-kB ligand; OPG, osteoprotegerin; sTNFR, soluble tumor necrosis factor-α receptor; sICAM, soluble intracellular adhesion molecule; sVCAM, soluble vascular cell adhesion molecule-1 (sVCAM-1).